Dec 12 Targeting EAAT2 as a Potential Therapeutic Target to Treat Alzheimer's Disease 4 to 5 p.m., Dec. 12, 2023 Andrew Tang Neuroscience Graduate Student University of Arizona Jan 16 Update on Huntington's Disease 4 to 5 p.m., Jan. 16, 2024 Thomas F. Vogt, Ph.D. Vice-President, Drug Discovery Genotype & Phenotype CHDI Foundation Jan 23 Neuroscience Community Data Blitz 5:30 to 7:30 p.m., Jan. 23, 2024 Feb 06 Title TBD 4 to 5 p.m., Feb. 6, 2024 Felice Dunn, Ph.D. Associate Professor University of California, San Francisco Feb 13 Title TBD 4 to 5 p.m., Feb. 13, 2024 Marc Freeman, Ph.D. Professor Oregon Health & Science University Feb 27 Title TBD 4 to 5 p.m., Feb. 27, 2024 Emily Bates, Ph.D. Associate Professor University of Colorado Mar 19 Title TBD 4 to 5 p.m., March 19, 2024 Kishore Kuchibhotla, Ph.D. Assistant Professor John Hopkins University Apr 02 Neuroscience Community Data Blitz 5:30 to 7:30 p.m., April 2, 2024 Apr 09 Title TBD 4 to 5 p.m., April 9, 2024 Mehrdad Jazayeri, Ph.D Associate Professor MIT
Dec 12 Targeting EAAT2 as a Potential Therapeutic Target to Treat Alzheimer's Disease 4 to 5 p.m., Dec. 12, 2023 Andrew Tang Neuroscience Graduate Student University of Arizona
Jan 16 Update on Huntington's Disease 4 to 5 p.m., Jan. 16, 2024 Thomas F. Vogt, Ph.D. Vice-President, Drug Discovery Genotype & Phenotype CHDI Foundation
Feb 06 Title TBD 4 to 5 p.m., Feb. 6, 2024 Felice Dunn, Ph.D. Associate Professor University of California, San Francisco
Feb 13 Title TBD 4 to 5 p.m., Feb. 13, 2024 Marc Freeman, Ph.D. Professor Oregon Health & Science University
Feb 27 Title TBD 4 to 5 p.m., Feb. 27, 2024 Emily Bates, Ph.D. Associate Professor University of Colorado
Mar 19 Title TBD 4 to 5 p.m., March 19, 2024 Kishore Kuchibhotla, Ph.D. Assistant Professor John Hopkins University
